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ABSTRACT
The placental labyrinth is the interface for gas and nutrient exchange
between the embryo and themother; hence its proper development is
essential for embryogenesis. However, the molecular mechanism
underlying development of the placental labyrinth, particularly in
terms of its endothelial organization, is not well understood. Here, we
determined that fibronectin leucine-rich transmembrane protein 2
(FLRT2), a repulsive ligand of the UNC5 receptor family for neurons,
is unexpectedly expressed in endothelial cells specifically in the
placental labyrinth. Mice lacking FLRT2 in endothelial cells exhibited
embryonic lethality at mid-gestation, with systemic congestion and
hypoxia. Although they lacked apparent deformities in the embryonic
vasculature and heart, the placental labyrinths of these embryos
exhibited aberrant alignment of endothelial cells, which disturbed the
feto-maternal circulation. Interestingly, this vascular deformity was
related to endothelial repulsion through binding to the UNC5B
receptor. Our results suggest that the proper organization of the
placental labyrinth depends on coordinated inter-endothelial
repulsion, which prevents uncontrolled layering of the endothelium.
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INTRODUCTION
The placenta is an organ that is found primarily in mammals and that
connects a developing fetus to the maternal uterine wall. The
placental labyrinth is a structure located on the fetal side of the
placenta, consisting of two major cellular components: trophoblasts
and endothelial cells (Cross et al., 1994). Trophoblasts, which are
the post-implantation derivatives of the trophectoderm, line the
maternal blood spaces, whereas endothelial cells, which arise from
the allantoic mesoderm of the embryo, border the fetal circulation
(Downs, 2002). These two juxtaposed layers provide the interface for
the bidirectional transfer of gases, nutrients, embryonic metabolic
end-products, and other molecules between the embryo and mother.
Hence, their proper formation is essential for the development of
embryos (Rossant and Cross, 2001). Vascular development consists
of three major processes: vasculogenesis, angiogenesis and vascular
remodeling. In principle, all three of these processes depend on or are
highly affected by signaling by vascular endothelial growth factor
(VEGF) and its receptors (Potente et al., 2011). However, the detailed
mechanisms surrounding VEGF vary greatly from organ to organ,
probably contributing to organ-specific vascular patterning (Adams
and Alitalo, 2007). The mechanisms that mediate vascularization of
the labyrinth share many of the molecules that are required for
embryonic vascular development, including hypoxia-inducible
factors and VEGF expressed in trophoblasts (Adelman et al., 2000;
Rossant and Cross, 2001; Cross et al., 2003; Hirashima et al., 2003).
However, the endothelial machinery that specifically mediates
establishment of the placental vasculature is largely unclear.
The nervous and vascular systems have been found to share a
number of guidance cues for network formation, including
members of the ephrin, netrin, semaphorin and slit families
(Adams and Eichmann, 2010; Quaegebeur et al., 2011).
Fibronectin leucine-rich transmembrane protein 2 (FLRT2) is a
member of the fibronectin leucine-rich transmembrane (FLRT)
family of proteins, which act as repulsive ligands of the UNC5
receptor family and as chemorepellents for neurons (Lacy et al.,
1999; Yamagishi et al., 2011; Seiradake et al., 2014). Outside of the
nervous system, FLRT2 is expressed in the epicardium, and its
global knockout leads to reduced thickness of the ventricular
myocardium, suggesting a role for FLRT2 in heart morphogenesisReceived 27 January 2017; Accepted 26 May 2017
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(Müller et al., 2011). However, the importance of FLRT2 as a
neurovascular cue and the detailed function of FLRT2 in
cardiovascular development are still unclear.
Here, we unexpectedly found that FLRT2 is expressed in
endothelial cells specifically in the placental labyrinth. Mice
lacking endothelial FLRT2 exhibited aberrant alignment of the
placental endothelium, which disturbed feto-maternal circulation and
might have been responsible for embryonic lethality at mid-gestation.
This vascular deformity was caused by a lack of the endothelial
repulsion that results from binding of FLRT2 toUNC5B.Netrin 1 has
long been thought to be the functional ligand of UNC5B, with
absence of netrin 1/UNC5B signaling being responsible for the
vascular defects in UNC5B-deficient mice (Lu et al., 2004; Larrivée
et al., 2007). Indeed, proteolytic fragments of netrin 1 bindUNC5B in
diabetic endothelial cells and increase vascular permeability (Miloudi
et al., 2016). However, in terms of developmental angiogenesis, the
situation regarding the role of netrin 1/UNC5B signaling is complex
and has been subject to debate; notably, the abnormalities reported for
UNC5B-deficient mice are absent in netrin 1 mutants (Serafini et al.,
1996; Wilson et al., 2006; Castets and Mehlen, 2010; Yung et al.,
2015). Our results suggest that FLRT2 is the predominant ligand that
is associated with the role of UNC5B in vascular development and
indicate that fine-tuning of vascular morphogenesis by inter-
endothelial repulsion contributes crucially to the development of
the placental labyrinth.
RESULTS
Endothelial FLRT2 is required for mid-gestation embryonic
survival
To elucidate the function of FLRT2 in vascular development, we
utilized Tie2-Cre mice, classically used to delete genes in
endothelial cells. By crossing these mice with indicator mice
( flox-CAT-EGFP), we observed Tie2-Cre expression in endothelial
cells and hematopoietic cells at embryonic day (E) 12.5 (Fig. S1A-
C), in agreement with results presented previously (Constien et al.,
2001). When Flrt2-flox mice were crossed with Tie2-Cre mice, the
resultant endothelial/hematopoietic-specific Flrt2 knockout
mice (Tie2-Cre+Flrt2flox/flox: herein referred to as Flrt2ΔEHC) died
between E13.5 and E14.5 (Fig. 1A,C). Contrary to this observation,
in a previous study, some global Flrt2 knockout mice survived until
weaning (Müller et al., 2011). This discrepancy could be explained
by the difference in genetic backgrounds, as the previous study
involved 129/C57Bl/6J mice, whereas our experiments were based
on pure C57Bl/6J mice.
Fig. 1. Endothelial FLRT2 is required for embryonic survival during mid-gestation. (A,B) Bright-field views of embryos with endothelial/hematopoietic-
specific Flrt2 knockout (Flrt2ΔEHC) or hematopoietic-specific Flrt2 knockout (Flrt2ΔHC) at E14.5. (C) Genotyping results from the Flrt2 conditional knockout
matings. For Tie2-Cre (endothelial/hematopoietic)-specific deletion, a Tie2-CrehetFlrt2flox/+ male was mated with Flrt2flox/flox females. For Vav1-iCre
(hematopoietic)-specific deletion, a Flrt2flox/flox male was mated with Vav1-iCrehetFlrt2flox/+ females. (D-P) Bright-field views of embryos (D-F), whole-mount
tissues stained with CD31 (G-N), or heart sections stainedwith the indicated antibodies at E12.5 (O,P). Significant congestion (arrowheads) was seen in Flrt2ΔEHC
embryos. ASMA, α-smooth muscle actin. (Q-S) Bright-field views of embryos or hearts at E14.5. (T) Genotyping results from the Flrt2 conditional knockout
matings. A CrehetFlrt2flox/+ male was mated with Flrt2flox/flox females. Scale bars: 500 µm (A,B,D-F,Q-S); 200 µm (G-N); 50 µm (O,P).
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To examine the relevance of hematopoietic FLRT2, we crossed
Flrt2-floxmice with Vav1-iCremice (de Boer et al., 2003), in which
expression of an optimized variant of Cre is expressed in all
hematopoietic cells but not in endothelial cells (Fig. S1D-F). The
hematopoietic Flrt2 knockout mice (Vav1-iCre+Flrt2flox/flox: herein
referred to as Flrt2ΔHC) were viable with no detectable
abnormalities (Fig. 1B,C).
To explore the cause of embryonic lethality in Flrt2ΔEHC mice,
they were examined at earlier stages of development. At E12.5, six
out of 13 Flrt2ΔEHC mice had no cardiac rhythm, and the remainder
showed systemic congestion (Fig. 1D-F) without any apparent
vascular deformities (Fig. 1G-N). However, at E11.5, none of
the defects seen at E12.5 was evident (Fig. S1G-K). These data
raised the possibility that the lack of FLRT2 in the endocardium
of Flrt2ΔEHC mice impaired cardiac morphogenesis and caused
heart failure at E12.5 because Tie2-Cre is also expressed in
the endocardium (Fig. S1L,M). However, morphological and
histological examination of the hearts of Flrt2ΔEHC mice showed
no apparent structural defects at E12.5 (Fig. 1E,F,O,P). The specific
role of FLRT2 in endocardium was examined by crosses with
Nfatc1-Cre mice (Wu et al., 2012), in which Cre is expressed in all
endocardial cells, some macrophages, and a few aortic endothelial
cells, but not in peripheral endothelial cells (Fig. S1N-Q). The
resultant Flrt2 knockout mice (Nfatc1-Cre+Flrt2flox/flox) were viable
and showed no detectable abnormalities (Fig. 1Q-T). Moreover,
utilizing αMHC-Cremice, we determined that FLRT2 expression in
the myocardium is also dispensable for embryonic development
(Fig. 1T). Together, these results indicated that endothelial FLRT2
was required for mid-gestation embryonic survival, and that a
separate crucial abnormality might exist outside the embryos
causing the lethality in Flrt2ΔEHC mice.
FLRT2 is expressed in endothelial cells specifically in the
placental labyrinth
The expression pattern of FLRT2 was examined through the
generation of Flrt2+/lacZ knock-in mice (Fig. S2A,B) and
examination of β-galactosidase expression in these mice. In
agreement with previously published results, we observed
abundant β-galactosidase expression in a population of neurons
and the epicardium (Yamagishi et al., 2011; Müller et al., 2011), but
not in embryonic endothelial cells (Fig. 2A-C,G,H,K-M).
Consistently, in the neonatal retina, we detected β-galactosidase
expression in retinal ganglion cells, but not in endothelial cells
(Fig. S2C,D), and deletion of Flrt2 in retinal ganglion cells by the
Fig. 2. FLRT2 is specifically expressed in endothelial cells in the placental labyrinth. (A-J) X-gal staining of whole-mount or section samples at E12.5. In Flrt2+/
lacZmice, β-galactosidase expression was detected in epicardial and somemesenchymal cells (arrows inG,H) and some placental endothelial cells (filled arrowheads
in J), but not in other endothelial cells, including the endocardium and the aortic endothelium (unfilled arrowheads in G,H). (K-O) Immunohistochemistry of
placental sections taken at E12.5. Flrt2+/lacZ embryos show β-galactosidase activity in some neuronal, stromal or epicardial cells (arrows in K-M), but not in endothelial
cells (unfilled arrowheads in K-M). Endothelial β-galactosidase activity was mosaically detected in the placentas of Flrt2+/lacZ mice (filled arrowheads in N), but
not in those ofFlrt2+/+mice (unfilled arrowheads inO). (P,Q) RT-PCRanalysis and quantification of FACS-sorted cells derived fromE12.5 placentas (n=5).Actb (Actin)
was used as loading control. Scale bars: 500 µm (A-D); 200 µm (E,F); 20 µm (G-O). **P<0.01; NS, not significant. Data are presented as mean±s.d.
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use of Chx10-Cre mice did not impair retinal vascularization
(Fig. S2E-G). It has previously been suggested (but not shown
directly) that FLRT2 is expressed in the placental endothelium
(Müller et al., 2011). Placental expression was therefore examined
in our Flrt2+/lacZ knock-in mice, which had a mosaic pattern of
β-galactosidase expression in endothelial cells of the placental
labyrinth (Fig. 2D-F,I,J,N,O). Immunohistochemistry with anti-
FLRT2 antibodies detected patchy expression localized around
endothelial cells in the placental labyrinth (Fig. S3A-C). This
endothelial FLRT2 immunoreactivity was diminished in Flrt2ΔEHC
but not in Flrt2ΔHC mice (Fig. S3D-I), confirming the specificity of
the antibodies. Reverse transcription polymerase chain reaction
(RT-PCR) analysis of cells sorted by fluorescence-activated cell
sorting (FACS) (Fig. S4) confirmed that Flrt2 expression was
enriched in CD31 (PECAM1)+ CD45 (PTPRC)− endothelial cells
in the placenta (Fig. 2P,Q). Moreover, Flrt2 expression was elevated
in placental CD31+ endothelial cells at E12.5 (Fig. S5), suggesting
that there is a requirement for endothelial FLRT2 around this
developmental stage.
Vasculature is poorly formed and aberrantly organized in
FLRT2-deficient placentas
Embryonic death occurring from E10 to E13 is attributed to failures
in cardiac function, hematopoiesis or placentation in many cases
(Papaioannou and Behringer, 2012). Our observation of the
expression of FLRT2 in placental endothelial cells suggested that
Flrt2ΔEHCmice might have placental defects, asCrewas expressed in
placental endothelial cells in Tie2-Cre but not in Vav1-iCre mice
(Fig. S6A,E). Placental Tie2-Cre expression was not observed in any
trophoblastic-lineage cells marked by CD9 or the monocarboxylate
transporters Mct1 (SLC16A1) or Mct4 (SLC16A3) (Fig. S6B-D),
was limited to endothelial cells, and was not seen in hematopoietic
cells (Fig. S6A), unlike in other tissues (Fig. S1A-C). Histological
examination of the placenta revealed that the labyrinth was poorly
formed and compact in Flrt2ΔEHC mice at E12.5 (Fig. 3A-F),
although the spongiotrophoblast layer was not affected (Fig. S7A-D).
Detailed analysis revealed that numbers of nucleated (fetal)
erythrocytes, which are normally contained within the endothelial
compartment, were considerably lower in Flrt2ΔEHC mice than in
controls, whereas non-nucleated (maternal) erythrocytes successfully
circulated in the epithelial compartment that was bordered by
trophoblasts (Fig. 3G-N,Q). Further analysis of the endothelial
structure of Flrt2ΔEHC mice showed that endothelial alignment was
aberrant and the endothelium was multi-layered, effectively
obstructing the vascular lumen (Fig. 3K-N). Immunohistochemistry
with laminin antibodies showed that the basement membrane was
invaginating into the endothelial lumen of placentas in Flrt2ΔEHC
mice (Fig. 3O,P). The rate of endothelial proliferation did not differ
Fig. 3. Poorly formed and aberrantly organized vasculature in FLRT2-deficient placentas. (A) Schematic depicting the anatomy of the mouse placenta.
A&V, arteries and veins. (B-Q) Immunohistochemistry and quantification of placental sections at E12.5 (n=5). Areas marked by the yellow dotted lines in
B-E indicate the placental labyrinth. Filled arrowheads indicate fetal nucleated erythrocytes. The labyrinth in control mice shows intact layering of endothelial cells
and trophoblasts between nucleated and non-nucleated erythrocytes (bidirectional arrows in M). The labyrinth of endothelial/hematopoietic-specific Flrt2
knockout (Flrt2ΔEHC) mice shows perturbed layering (dotted bidirectional arrows in N; unfilled arrowheads in P). Scale bars: 500 µm (B-E); 200 µm (G,H); 50 µm
(I,J,O,P); 10 µm (K-N). *P<0.05. Data are presented as mean±s.d.
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between control andFlrt2ΔEHCmice (Fig. S7E-G), suggesting that the
observed endothelial multi-layering could not be attributed to
aberrant proliferation.
Increased hypoxia in FLRT2-deficient embryos
The consequences of perturbed feto-maternal gas exchange were
explored by examination of the embryos and placentas of Flrt2ΔEHC
mice. Bright-field microscopy images suggested that the branches
of the umbilical arteries and veins in Flrt2ΔEHC mice were not
occluded, but instead contained dark-colored blood (Fig. 4A-C),
possibly as a result of impaired gas exchange in the labyrinth.
Accumulation of a hypoxia marker, pimonidazole, was significantly
higher in Flrt2ΔEHC embryos than in controls, notably in the head
region, where oxygen consumption is probably very high (Smith
et al., 2013) (Fig. 4D-G).
FLRT2 repulses endothelial cells in vitro through the UNC5B
receptor
The precise action of FLRT2 on endothelial cells was elucidated
with an in vitro assay involving primary cultures of endothelial
cells. Previously, X-ray crystallography (Seiradake et al., 2014)
revealed that FLRT2 binds to FLRT2 (homophilic binding) as well
as to UNC5B, UNC5C and UNC5D (heterophilic binding) via
different extracellular regions of FLRT2 (Fig. 5A). FLRT2 is known
to act as a repulsive cue on neurons through binding to UNC5B and
UNC5D (Yamagishi et al., 2011). Among the UNC5 proteins, only
UNC5B is indispensable for embryonic development, and Unc5b
knockouts are lethal at approximately E12.5, similar to the
Flrt2ΔEHC genotype (Lu et al., 2004; Navankasattusas et al.,
2008). It was, therefore, important to select an endothelial line that
expressed both FLRT2 and UNC5B. Human umbilical vein
endothelial cells (HUVECs) express these two genes at high
levels, making this cell line appropriate for further in vitro studies
(Fig. 5B). To evaluate whether the repulsive mechanism of
interaction between FLRT2 and UNC5B acts in endothelial cells
in the same way as in neuronal cells (Yamagishi et al., 2011;
Seiradake et al., 2014), a Transwell assay and a stripe assay were
performed in HUVECs with recombinant FLRT2 and UNC5B
proteins. Compared with vehicle only, FLRT2 significantly
decreased migration of HUVECs in the Transwell assay and
resulted in repulsion of the cells away from stripes containing the
recombinant protein (Fig. 5C-L; Movie 1). These effects were
almost completely abolished by neutralization of FLRT2 by the
addition of UNC5B, suggesting that the repulsive action of
extracellular FLRT2 was mediated by heterophilic interaction with
UNC5B, and not by homophilic binding to FLRT2 (Fig. 5C-L).
Similar effects were seen with human aortic endothelial cells
(HUAECs) (Fig. 5M,N), which express UNC5B but have little or no
endogenous expression of FLRT2 (Fig. 5B). Human dermal
lymphatic endothelial cells (HDLECs) have little or no UNC5B
expression (Fig. 5B), and they did not show repulsion from FLRT2
in stripe assays (Fig. S8A), confirming that the repulsive action
of FLRT2 was mediated by UNC5B. To evaluate the role of
endogenous UNC5B expression in seeded cells, knockdown of
Unc5b by small interfering RNA (siRNA) was performed in
HUVECs. Treatment with si-Unc5b significantly reduced the
repulsive action of FLRT2 on HUVECs (Fig. S8B).
Notably, the effects of FLRT2 on proliferation in HUVECs and
HUAECs were negligible (data not shown), suggesting that, in vitro,
FLRT2 is involved primarily in endothelial repulsion and not in
proliferation, which is in agreement with the in vivo data in placentas
of Flrt2ΔEHC mice (Fig. S7E-G).
Unc5b deletion recapitulates the vascular defects observed
in Flrt2-deficient placentas
Our results suggested that FLRT2 signals through UNC5B in the
placental labyrinth. Endothelial cells in the labyrinth express
UNC5B at high levels (Navankasattusas et al., 2008). In Unc5b-
deficient mice, the results of a previous study with Doppler-flow
analysis showed that blood flow is reversed in diastole within the
umbilical arteries, suggesting uteroplacental insufficiency
(Navankasattusas et al., 2008). Immunohistochemical analysis of
histological abnormalities in placentas of Unc5b−/− mice showed
that the area of the placental labyrinth was significantly reduced at
E12.5 compared with Unc5b+/+ mice (Fig. 6A,B,I), although the
spongiotrophoblast layer was not affected (Fig. S9). Similar to our
observations in Flrt2ΔEHC mice, placental endothelial alignment
was perturbed and fetal circulation was disrupted in Unc5b−/− mice
(Fig. 6C-H). Taken together, these data suggest that the vascular
abnormalities in Flrt2ΔEHC placentas are associated with the
repulsive action of FLRT2, acting on the UNC5B receptor on
endothelial cells.
Fig. 4. Increased hypoxia occurs in FLRT2-deficient embryos. (A-C) Bright-field views of placentas at E12.5. Branches of umbilical arteries and veins contain
dark-colored blood in endothelial/hematopoietic-specific Flrt2 knockout (Flrt2ΔEHC) mice (arrowheads). (D-G) Whole-mount or sectioned specimens showing
pimonidazole incorporation at E12.5 and their quantification (n=5). BF, bright field. Scale bars: 500 µm (A-D); 200 µm (E,F). *P<0.05. Data are presented as
mean±s.d.
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VEGF/VEGF receptor signaling is required for vascular growth
during development throughout the body. However, the cellular
andmolecular mechanisms associated with vascular morphogenesis
in each organ vary, and organ-specific angiogenesis involves
various VEGF-dependent and VEGF-independent processes. Our
results have identified a cellular and molecular mechanism that is
specifically active in placental angiogenesis. We have demonstrated
that formation of the placental labyrinth requires coordinated inter-
endothelial repulsion mediated by FLRT2, which is known to be a
repulsive guidance cue for axons, acting via binding to the UNC5B
receptor. Our data suggested that, in both Flrt2ΔEHC mice and
Unc5b−/−mice, fetal blood circulation in the placental labyrinth was
blocked because of disorganization of vascular structures, impairing
feto-maternal gas exchange (Fig. 6J).
The requirement for FLRT2 in development was first
demonstrated in whole-body Flrt2 knockout mice (Müller et al.,
2011), in which the thickness of the ventricular walls was severely
reduced at E11.5, which is earlier than our observation of placental
defects in Flrt2ΔEHC mice. The phenotype of the whole-body Flrt2
knockout mice was primarily caused by impaired epicardial
integrity, without any endocardial abnormality. In Flrt2ΔEHC
mice, we observed thinning of ventricular walls at E14.5 (data not
shown) but not at E12.5, suggesting that placental defects precede
cardiac defects in these mice. Overall, the phenotypewe observed in
Flrt2ΔEHC mice seems to be independent of the cardiac defects
previously observed in global Flrt2 knockout mice (Müller et al.,
2011).
An important aspect of our findings is that they suggest that
FLRT2 is the predominant ligand of UNC5B, which explains the
severe vascular defects observed in UNC5B-deficient mice (Lu
et al., 2004; Navankasattusas et al., 2008). Netrin 1 has long been
thought to be the ligand of UNC5B that is involved in angiogenesis.
Treatment of endothelial cells with netrin 1 results in tip-cell-
filopodia retraction, and this effect is abolished in UNC5B-deficient
mice. Morpholino knockdown of ntn1 (the gene encoding netrin 1)
in zebrafish has demonstrated the repulsive guidance activity of
netrin 1 for endothelial cells through UNC5B signaling (Lu et al.,
2004). However, Ntn1 knockout mice survive until birth and have
no vascular abnormalities (Yung et al., 2015), indicating that netrin
1 is not necessarily the only ligand for UNC5B, and an absence of
netrin 1 might be compensated for by other ligands in vivo,
specifically roundabout homolog 4 or netrin 4 (Koch et al., 2011;
Lejmi et al., 2008; Li et al., 2012). Conflicting reports exist
regarding the role of netrin 1 as either a pro-angiogenic or anti-
angiogenic factor (Lu et al., 2004; Larrivée et al., 2007; Wilson
et al., 2006; Castets and Mehlen, 2010). One argument that appears
to resolve this dilemma is the ability of netrin 1 to block apoptosis
that would otherwise be induced by unbound UNC5B receptors,
thus promoting the survival of endothelial cells during angiogenesis
(Castets et al., 2009).
Vascular repulsive cues are usually provided by non-endothelial
cells around blood vessels. For example, semaphorin 3E, which is
secreted by retinal neurons, binds plexin D1-expressing endothelial
tip cells and represses their ability to project filopodia (Kim et al.,
2011). Notably, consequences of the loss of semaphorin 3E or
Fig. 5. FLRT2 repulses endothelial cells in vitro through the UNC5B receptor. (A) Model showing the FLRT2-FLRT2 and FLRT2-UNC5 interactions. (B) RT-
PCR analysis of FLRT2 and UNC5B expression in several different cultured cell types. ACTB (Actin) was used as loading control. (C-N) Transwell and
stripe assays with HUVECs or HUAECs, and quantification of the results (n=5). Arrows in H-K indicate cells located on the surface where the indicated proteins
exist. Scale bars: 50 µm. **P<0.05; *P<0.01; NS, not significant. Data are presented as mean±s.d.
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plexin D1 are unevenness of the growing front and reduction in
branching of the vascular network. Our results also provide
evidence that a lack of proper endothelial repulsion results in an
overall reduction in vascular growth. Endothelial cell-derived
semaphorin 3A has been shown to repel filopodia projection by
endothelial tip cells through plexin A1 and neuropilin 1 receptors
(Ochsenbein et al., 2016). In agreement with this result, in our
model endothelial FLRT2 acts on neighboring UNC5B-expressing
endothelial cells to fine-tune alignment and prevent aberrant
layering. Upon disruption of FLRT2/UNC5B signaling,
endothelial clustering without a change in cell number might lead
to failure to expand the total area of vascular plexus.
In contrast to the mosaic pattern of expression of FLRT2 that we
observed in endothelial cells, UNC5B has previously been
ubiquitously detected in all placental endothelial cells
(Navankasattusas et al., 2008). Transmembrane FLRT2 proteins
are proteolytically cleaved to release soluble ectodomains
(Seiradake et al., 2014; Yamagishi et al., 2011) that diffuse into
the extracellular spaces. Thus, it is likely that one FLRT2-
expressing endothelial cell acts repulsively on multiple UNC5B-
expressing cells, both in paracrine and autocrine manners. Our
results indicated that the luminal/abluminal polarity was somehow
disrupted in the Flrt2ΔEHC mice, as the basement membrane was
invaginating into the endothelial lumen. At the same time,
endothelial cells were abnormally clustered, suggesting their
impaired alignment or deregulated migration. To evaluate these
kinetic components (polarity, alignment and migration)
individually will require in vivo live imaging, which could not be
applied to the mouse placenta with technology available at the time
of this study. Although we could not clearly separate the defects in
alignment, polarity and migration, the results of our in vitro studies
suggest that the defects in Flrt2ΔEHCmice involve a mixture of these
factors. Endothelial collapse, which is another potential cause of
this kind of endothelial clustering, was not apparent, as indicated by
the presence of the apoptotic marker cleaved caspase 3 in very few
endothelial cells; also, the number of such apoptotic endothelial
cells was equal in placentas of control and Flrt2ΔEHCmice (data not
shown).
Finally, our data have demonstrated that a FLRT2-UNC5B
interaction, resulting in inter-endothelial repulsion, is required for
the proper organization of endothelial structures in the placental
labyrinth. It will be of interest to explore the roles of similar
repellent mechanisms directed by other guidance molecules in the
development of other vascular beds. Furthermore, it will be
essential to determine whether FLRT2 contributes to adult
angiogenesis, in particular angiogenesis associated with certain
neoplasms, as tumor angiogenesis often utilizes developmentally
important angiogenic molecules (Kubota, 2012).
MATERIALS AND METHODS
Mice and analysis
Animal care was performed in accordance with the Guidelines of Keio
University for Animal and Recombinant DNA experiments. The Tie2-Cre
(Arita et al., 2014), Chx10-Cre (Muranishi et al., 2011; Yoshikawa et al.,
2016), Unc5b−/− (Wilson et al., 2006), Nfatc1-Cre (Wu et al., 2012),
αMHC-Cre (Agah et al., 1997) and flox-CAT-EGFP (Kawamoto et al.,
2000) mice have been described previously. Vav1-iCremice (de Boer et al.,
2003) were obtained from the Jackson Laboratory. An embryonic stem cell
clone [Flrt2tm1a(EUCOMM)Wtsi] obtained from the European Conditional
Mouse Mutagenesis Program (EUCOMM) was used to generate Flrt2-flox
mice. To generate Flrt2+/lacZ mice, the Flrt2 knock-in allele was generated
by homologous recombination of exon 2, replaced by a lacZ gene followed
by a loxP-flanked PGK-promoter-driven neomycin gene. Flrt2+/lacZ mice
were maintained on a CD1 background, and the rest of the mutant mice were
crossed with C57BL/6J mice at least ten times. For Vav1-iCre-specific
deletion, a Flrt2flox/floxmale was mated with Vav1-iCrehetFlrt2flox/+ females.
Otherwise, a CrehetFlrt2flox/+male was mated with Flrt2flox/flox females. For
analysis, embryos and neonates of both sexes were used without exact
determination.
Fig. 6. UNC5B deletion recapitulates the vascular defects observed in Flrt2-deficient placentas. (A-I) Immunohistochemistry and quantification of placental
sections taken at E12.5 (n=5). The yellow dotted lines in A,B encircle the placental labyrinth. Intact layering of endothelial cells between nucleated and non-
nucleated erythrocytes was visible in Unc5b+/+ placentas (bidirectional arrows in E, unfilled arrowheads in G), but was disrupted in Unc5b−/− placentas (dotted
bidirectional arrows in F, filled arrowheads in H). (J) Schematic depicting the labyrinth structures of placentas of control, endothelial/hematopoietic-specific Flrt2
knockout (Flrt2ΔEHC), and Unc5b−/− mice. Scale bars: 500 µm (A,B); 200 µm (C,D); 10 µm (E-H). *P<0.05. Data are presented as mean±s.d.
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Preparation of tissue sections
Surgically dissected tissues were fixed overnight in 4% paraformaldehyde
(PFA) in PBS, and then snap-frozen in optimal cutting temperature (OCT)
compound (Sakura Finetechnical, Tokyo, Japan). All placental specimens
were sectioned (10-15 µm thick) at the plane where umbilical arteries and
veins were attached.
Preparation of whole-mount tissues
Enucleated eyes were fixed for 20 min in 4% PFA in PBS and then dissected
as described previously (Okabe et al., 2014). Retinal cups were post-fixed
for 20 min. Other tissues were dissected out from embryos and fixed
overnight in 4% PFA in PBS. All whole-mount tissues were stained as
described below.
Immunostaining
IHC of whole-mount samples or tissue sections was performed as described
previously (Kubota et al., 2011). The primary monoclonal antibodies
used were hamster anti-CD31 (Chemicon, MAB1398Z; 1:1000), Cy3-
conjugated mouse anti-α-smooth muscle actin (Sigma-Aldrich, C6198;
1:500), rat anti-Ter119 (also known as LY76) (R&D Systems, MAB1125;
1:1000), rabbit anti-CD9 (Abcam, ab92726; 1:500) and rat anti-F4/80 (also
known as ADGRE1) (Serotech, MCA497R; 1:500). The primary polyclonal
antibodies used were Alexa Fluor 488-conjugated rabbit anti-GFP
(Molecular Probes, A21311; 1:500), goat anti-GFP (Rockland, 600-101-
215; 1:2000), rabbit anti-laminin (Sigma-Aldrich, L9393; 1:500), rabbit
anti-ERG (Abcam, ab92513; 1:2000), rabbit anti-β-galactosidase
(Millipore, AB986; 1:500), chicken anti-Mct1 (Millipore, AB1286-I;
1:200), rabbit anti-Mct4 (Millipore, AB3314P; 1:200), goat anti-FLRT2
(R&D Systems, AF2877; 1:1000), and rabbit anti-trophoblast specific
protein alpha (Tspα; also known as TPBPA) (Abcam, ab104401; 1:1000).
Secondary antibodies used were Alexa Fluor 488-conjugated IgGs
(Molecular Probes, A11034, A11006, A11055; 1:500) or Cy3/Cy5-
DyLight549/DyeLight649-conjugated IgGs (Jackson ImmunoResearch,
711-165-152, 112-165-167, 127-165-160, 711-605-152, 112-605-167,
127-605-160; 1:500). For the 5-ethynyl-2’-deoxyuridine (EdU)
incorporation assay, the Click-iT EdU Alexa Fluor 488 Imaging Kit
(Invitrogen, C10337) was used. In brief, pregnant mice were injected
intraperitoneally 2 h before euthanasia with 0.5 ml EdU solution
(0.5 mg ml−1) and stained according to the manufacturer’s protocol. For
the detection of hypoxic cells, the Hypoxyprobe-1 Plus Kit (Chemicon,
HP2-100) was used according to the manufacturer’s instructions. In brief,
60 mg kg−1 pimonidazole was injected intraperitoneally into pregnant mice
30 min before euthanasia, and sections were stained with Hypoxyprobe
Mab1-FITC. For nuclear staining, specimens were treated with 4′,6-
diamidino-2-phenylindole (DAPI) (Molecular Probes, D-1306).
X-gal staining of tissue whole-mount samples and sections
Embryos, retinas and placentas were fixed for 30 min in 1% glutaraldehyde
in PBS and stained as whole-mount samples or snap-frozen in OCT
compound before sectioning. The samples were then incubated for 2 h for
whole mounts or 1 h for sections at 37°Cwith 1 mg ml−1 5-bromo-4-chloro-
3-indolyl-β-D-galactopyranoside (X-gal) in a standard X-gal reaction buffer
(35 mM potassium ferrocyanide, 35 mmol l−1 potassium ferricyanide,
2 mmol l−1 MgCl2, 0.02% NP-40 and 0.01% sodium deoxycholate in
PBS). For whole-mount embryos and placentas, stained tissues were
clarified by immersion in a solution of benzyl alcohol and benzyl benzoate
(1:2). For sectioned specimens, Nuclear Fast Red (Thermo Fisher Scientific)
was used for counter-staining.
Confocal microscopy
Fluorescent images were obtained using a confocal laser scanning
microscope (FV1000; Olympus, Tokyo, Japan). Quantification of cells or
parameters of interest was conducted in a 600×600 µm field of view (for all
in vitro assays), a 200×200 µm field of view (for counting EdU+ cells) or the
entire section (for measuring radial growth and the labyrinth area) in
scanned images. ImageJ software (NIH, Bethesda, MD, USA) was used for
the quantification of indicated areas in scanned images.
Flow cytometric analysis and cell sorting
Placental tissues were incubated for 20 min at 37°C in Dulbecco’s Modified
Eagle’s Medium (DMEM) containing 1 mg ml−1 collagenase IV from
Clostridium histolyticum (Sigma-Aldrich), 1 U ml−1 Dispase (Thermo
Fisher Scientific) and 1 U ml−1 DNase (Takara-Bio), before cells were
dissociated by gentle trituration. Dissociated single cells were preincubated
with Fc block (Becton Dickinson) to avoid nonspecific binding of
antibodies, and then incubated with allophycocyanin (APC)-conjugated
anti-CD31 (Biolegend, 102510; 1:500) and APC-Cy7-conjugated anti-
CD45 (Biolegend, 103116; 1:500). Stained samples were analyzed and
sorted by SORP FACSAria (Becton Dickinson) with FlowJo software
(TreeStar, Ashland, OR, USA), as described previously (Kubota et al.,
2011). Debris and dead cells were excluded by forward and side scatter and a
negative gate for propidium iodide staining (Fig. S4). FACS studies
routinely included unstained control samples and compensation tubes for
APC and APC-Cy7. With these negative and positive control tubes,
fluorescence voltages and the compensation matrix were set according to the
manufacturer’s instructions and applied to all the samples that were
analyzed.
RT-PCR analysis
Total RNAwas prepared from placental tissues or cultured cells, and reverse
transcription was performed using Superscript II (Invitrogen). cDNA
samples were then subjected to PCR amplification with the following
primers: (1) mouse Flrt2, 5′-AGACAAGGCTGCCAGATTACA-3′ and 5′-
TAAAATGCAACGTGATGGGG-3′; (2) mouse Cd31, 5′-GCTGAGGA-
AAACTCCTTCAC-3′ and 5′-TTCTGGATGGTGAAGTTGGC-3′;
(3) mouse Mct1, 5′-ATTGGAGGGCCAGTGGGATA-3′ and 5′-TCAGA-
CAGGGCTCTCCTCCT-3′; (4) mouse Mct4, 5′-GCTGTGGTGGACGA-
GGGT-3′ and 5′-TGGTTTCCGGGGTATGAA-3′; (5) mouse β-actin, 5′-
ATGGATGACGATATCGCTGC-3′ and 5′-AGCACTGTGTTGGCATA-
GAG-3′; (6) human FLRT2, 5′-GGAGAAGACGCAGCCGTCAG-3′ and
5′-TTGAAGTCCAGAACTCCAGC-3′; (7) human UNC5B, 5′-ACATT-
TGGAGTGGCAGCCAG-3′ and 5′-TCGCTTTGGTGGCAAAGTAA-3′;
(8) human β-actin, 5′-ATGGATGATGATATCGCCGC-3′ and 5′-TACA-
GGTCTTTGCGGATGTC-3′.
Western blotting
Western blot analysis of embryonic tissues was performed as described
elsewhere (Okabe et al., 2014). The primary antibodies used were goat anti-
FLRT2 (R&D Systems, AF2877; 1:2000), rabbit anti-β-galactosidase
(Cappel Laboratories, 08559761; 1:500) and mouse anti-tubulin (Sigma-
Aldrich, T5168; 1:2000).
Transwell assay
HUVECs, HUAECs or HDLECs (Takara-Bio) were cultured in EGM-2
medium (Takara-Bio) at 37°C in 20% O2 following a previously described
protocol (Okuno et al., 2012). Chemotaxis was assessed using Transwell
polyester-membrane cell-culture inserts (3.0 µm pore, Sigma-Aldrich)
according to the method described previously (Kubota et al., 2011). Both
the upper and lower surfaces of the membranes were coated with 0.1%
gelatin, and 600 µl EGM-2 medium with or without 5 µg ml−1 recombinant
FLRT2 (Abcam) and/or 5 µg ml−1 recombinant human UNC5B (R&D
Systems) was added to the lower wells of 24-well plates. Cells were
re-suspended in EGM-2, added to the upper wells (1×105 cells per well),
and incubated for 12 h. Cells were then fixed by 4% PFA in PBS and stained
with DAPI. The number of cells attached to the lower surfaces of the
membranes were counted by confocal microscopy as described above.
Stripe assay
Stripe assays were performed as described previously (Yamagishi et al.,
2011). Briefly, 50 µg ml−1 recombinant control and FLRT2 proteins
(Abcam) were pre-clustered with FITC-conjugated anti-His antibodies
(Abcam; ab1270; 1:20) in PBS for 30 min. For competition assays, pre-
clustered FLRT2 proteins were preincubated with 50 µg ml−1 recombinant
UNC5B proteins (R&D Systems) for 45 min. These protein solutions were
injected into matrices (90 µm width) placed on 60 mm dishes (Knöll et al.,
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2007). After incubation at 37°C for 30 min, the dishes were washed with
PBS and the matrices were carefully removed, resulting in green fluorescent
stripes. The stripes were coated with 50 µg ml−1 bovine serum albumin as
black stripes for 30 min at 37°C and washed three times with PBS. The
stripes were further incubated with 20 µg ml−1 laminin (Invitrogen) at 37°C
for 1 h, and 10,000 HUVECs or HUAECs were cultured at 37°C for 24 h on
the stripes. After incubation, cells were fixed with 4% PFA for 20 min and
permeated with 0.3% Triton X-100 in PBS for 15 min at room temperature.
DAPI was used to visualize the nuclei, and the total numbers of cells on
green and black stripes were quantified. To create movies, phase-contrast
pictures were obtained every 5 min from 0.5 h to 16 h after plating the cells
and merged with images in the fluorescent channel using Biostation (Nikon,
Japan). For RNA interference, HUVECs were washed once with OptiMEM
(Thermo Fisher Scientific) and transfected with 40 nmol l−1 siRNA Duplex
(Qiagen) using 6 µl ml−1 Lipofectamine RNAiMAX (Invitrogen) in
OptiMEM according to the manufacturer’s instructions. After 4 h, the
transfection mediumwas removed and complete culture mediumwas added.
Cells were cultured for a further 48 h before applying to the stripe assay. To
knock down Unc5b, FlexiTube siRNA GS219699 for UNC5B (Qiagen)
was used. As a control, a siRNA-negative control duplex oligonucleotide
(5′-CUUACGCUGAGUACUUCGATT-3′, 5′-UCGAAGUACUCAGCG-
UAAGTT-3′; Sigma) was used.
Statistics
Results are expressed as mean±s.d. The comparisons between the averages
of the two groups were evaluated using a two-tailed Student’s t-test.
P-values of <0.05 were considered statistically significant.
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 Supplementary Figure 1. Expression patterns of Cre in each Cre line. 
(A–F) Expression of green fluorescent protein (GFP) was used as a reporter of Cre 
expression. Whole-mount immunostaining of tissues at embryonic day (E)12.5. (G–K) 
Bright-field views of embryos and hearts, or whole-mount tissues stained with CD31 at 
E11.5. (L, M) Heart sections stained with the indicated antibodies at E12.5. GFP was 
detected in endocardial cells (closed arrowheads) and macrophages (open arrowheads). 
(N–Q) Whole-mount tissues or heart sections at E12.5 stained with the indicated 
antibodies. GFP was detected in endocardial (closed arrowheads) and some aortic 
endothelial cells (open arrowheads) and macrophages (arrows). Scale bars: 500 µm 
(G–I); 50 µm (A–F, J–Q). 
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Supplementary Figure 2. Flrt2 is expressed but is dispensable in postnatal retinal 
neurons. 
(A) Scheme of the Flrt2–LacZ knock-in allele generated by homologous 
recombination of exon II, containing the entire open reading frame (ORF) of the mouse 
Flrt2 gene. Exon II of the Flrt2 allele was replaced by a LacZ gene followed by a 
loxP-flanked PGK-promoter-driven neomycin gene. Recombination in the embryonic 
stem cell clone was confirmed by Southern blotting using probes A and B. N, NcoI site 
for probe A; K, Kpn site for probe B. (B) Western blot analysis showing FLRT2 and 
β-galactosidase protein levels. Compared with Flrt2+/+, FLRT2 protein levels were 
lower in heterozygotes and absent in Flrt2lacZ/lacZ mice, whereas β-galactosidase 
appeared in heterozygotes and was increased in Flrt2lacZ/lacZ mice. Tubulin was used as a 
loading control. (C, D) X-gal staining of whole-mount retinas at P6. (E–G) 
Immunohistochemistry and quantification of P6 retinas stained with CD31 (n = 5). 
Scale bars: 500 µm (C, E, F); 50 µm (D). NS, not significant. Data are presented as the 
mean ± SD. 
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Supplementary Figure 3. FLRT2 protein is detected around placental endothelial 
cells. 
Immunohistochemistry with anti-FLRT2 antibodies on section specimens of placentas 
at embryonic day (E)12.5. FLRT2 was detected around endothelial cells in control and 
hematopoietic-specific Flrt2-knockout (Flrt2ΔHC) mice (closed arrowheads), and this 
immunoreactivity was diminished in endothelial/hematopoietic-specific Flrt2-knockout 
(Flrt2ΔEHC) mice (open arrowheads). Scale bar: 10 µm. 





















Supplementary Figure 4. Sorting strategy of CD31+ or CD45+ cells from placental 
tissues. 
Stained samples were sorted by SORP FACSAria. Debris and dead cells were excluded 















CD31 APC CD45 APC-Cy7
Q1-1: CD31-CD45+ cells
Q3-1: CD31-CD45- cells
Q4-1: CD31+ CD45- cells





















Supplementary Figure 5. Flrt2 expression in FACS-sorted CD31+ endothelial cells. 
Flrt2 expression in CD31+ endothelial cells, determined by RT-PCR, is abundant in the 












































Supplementary Figure 6. Placental expression of Tie2-Cre/Vav1-iCre. 
Immunohistochemistry of placental sections taken at embryonic day (E)12.5. Cre 
recombinase expression (indicated by the presence of green fluorescent protein) in 
placental endothelial cells was detected in Tie2–Cre (A‒D) but not in Vav1–iCre (E) 
crosses. In Tie2 ‒ Cre mice, GFP expression was not observed in any 
trophoblastic-lineage cells marked by CD9, Mct1 (closed arrowhead), or Mct4 (open 
arrowhead), but was restricted to endothelial cells (arrow) (D). Scale bars: 50 µm (A‒C, 
E); 10 µm (D). 





























































Supplementary Figure 7. Spongiotrophoblasts and endothelial proliferation are not 
impaired in FLRT2-deficient placentas. 
(A–G) Immunohistochemistry and quantification of placental sections taken at 
embryonic day (E)12.5 (n = 5). Areas marked by the dotted line in A, B indicate the 
spongiotrophoblast layer. The morphology of spongiotrophoblasts (closed arrowheads 
in C, D) neighboring the labyrinth was not altered in endothelial/hematopoietic-specific 
Flrt2-knockout (Flrt2ΔEHC) mice. Open arrowheads in E, F indicate proliferating 
endothelial cells. Scale bars: 500 µm (A, B); 50 µm (C‒F). NS, not significant. Data are 
presented as the mean ± SD. 







































































Supplementary Figure 8. FLRT2 repulses endothelial cells through the UNC5B 
receptor 
(A, B) Stripe assays with human dermal lymphatic endothelial cells (HDLECs) or 
human umbilical vein endothelial cells (HUVECs) under small interfering RNA 
(siRNA)-mediated knockdown of Unc5b, and quantification of the results (n = 5). **P 
<0.01; NS, not significant. Data are presented as the mean ± SD. 





























CD31 TspD DAPI TspD DAPI 
Supplementary Figure 9. Spongiotrophoblasts are not impaired in Unc5b-deficient 
placentas. 
(A–D) Immunohistochemistry of placental sections taken at embryonic day (E)12.5. 
Areas marked by the dotted line in A, B indicate the spongiotrophoblast layer. The 
morphology of spongiotrophoblasts (closed arrowheads in C, D) neighboring the 
labyrinth was not altered in Unc5b−/− mice. Scale bars: 500 µm (A, B); 50 µm (C, D). 





















Supplementary Movie 1. FLRT2 repulses endothelial cells in vitro. 
Representative movies of the stripe assay with human umbilical vein endothelial cells 
(HUVECs) cultured on green stripes coated with FLRT2 proteins.  
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